Correlation Between Denali Therapeutics and Atea PharmaceuticalsI
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Atea PharmaceuticalsI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Atea PharmaceuticalsI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Atea PharmaceuticalsInc, you can compare the effects of market volatilities on Denali Therapeutics and Atea PharmaceuticalsI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Atea PharmaceuticalsI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Atea PharmaceuticalsI.
Diversification Opportunities for Denali Therapeutics and Atea PharmaceuticalsI
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Denali and Atea is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Atea PharmaceuticalsInc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea PharmaceuticalsInc and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Atea PharmaceuticalsI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea PharmaceuticalsInc has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Atea PharmaceuticalsI go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Atea PharmaceuticalsI
Given the investment horizon of 90 days Denali Therapeutics is expected to generate 1.17 times more return on investment than Atea PharmaceuticalsI. However, Denali Therapeutics is 1.17 times more volatile than Atea PharmaceuticalsInc. It trades about -0.02 of its potential returns per unit of risk. Atea PharmaceuticalsInc is currently generating about -0.03 per unit of risk. If you would invest 3,168 in Denali Therapeutics on January 25, 2024 and sell it today you would lose (1,612) from holding Denali Therapeutics or give up 50.88% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Denali Therapeutics vs. Atea PharmaceuticalsInc
Performance |
Timeline |
Denali Therapeutics |
Atea PharmaceuticalsInc |
Denali Therapeutics and Atea PharmaceuticalsI Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Denali Therapeutics and Atea PharmaceuticalsI
The main advantage of trading using opposite Denali Therapeutics and Atea PharmaceuticalsI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Atea PharmaceuticalsI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea PharmaceuticalsI will offset losses from the drop in Atea PharmaceuticalsI's long position.Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular TherapeuticsInc | Denali Therapeutics vs. Ascendis Pharma AS |
Atea PharmaceuticalsI vs. Immix Biopharma | Atea PharmaceuticalsI vs. Cns Pharmaceuticals | Atea PharmaceuticalsI vs. Hepion Pharmaceuticals | Atea PharmaceuticalsI vs. AVROBIO |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Stocks Directory Find actively traded stocks across global markets | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |